文献速递腹部CT

光谱肝脏CT碘图细胞外容积分数用于肝纤维化分级

Hepatic fibrosis grading with extracellular volume fraction from iodine mapping in spectral liver CT.
PubMed 文献 · Eur J Radiol · 2021-02-16

研究纳入144例在光谱肝脏CT后四周内行肝切除或活检的患者,用平衡期计算碘图细胞外容积分数(ECV-碘)和HU法细胞外容积分数(ECV-HU)。ECV-碘在肝硬化组高于F0-1组和F2-3组,失代偿肝硬化高于代偿肝硬化;ECV-碘检测≥F2和肝硬化的AUC分别为0.82和0.81,均高于ECV-HU。结论认为ECV-碘能检测临床显著肝纤维化和肝硬化。

要点

  • ECV-碘检测≥F2的AUC为0.82,截断值>26.9%
  • ECV-碘检测肝硬化的AUC为0.81,截断值>29%
  • ECV-碘诊断效能高于ECV-HU(≥F2的AUC 0.82 vs 0.69;肝硬化的AUC 0.81 vs 0.74)

诊断标准与关键数值

  • ECV-碘检测≥F2的AUC为0.82,截断值>26.9%
  • ECV-碘检测肝硬化的AUC为0.81,截断值>29%
  • ECV-HU检测≥F2的AUC为0.69,检测肝硬化的AUC为0.74
  • 肝硬化ECV-碘为33.6±6.8%,高于F0-1的25.0±3.7%和F2-3的28.3±3.4%(P<0.001)
  • 失代偿肝硬化ECV-碘为36.5±7.2%,高于代偿肝硬化的30.7±5.0%(P<0.001)

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

PURPOSE: To determine whether hepatic extracellular volume fraction (ECV) obtained from iodine density map (ECV-iodine) can be used to estimate hepatic fibrosis grade and to compare performance with ECV measured using Hounsfield units (ECV-HU).

METHODS: From December 2016 to March 2019, patients who underwent liver resection or biopsy within four weeks after spectral liver CT were included. ECV-iodine and ECV-HU were calculated using the equilibrium phase. Within each of these, comparison of ECVs was made for different fibrosis grades (F0 - 1 vs. F2 - 3 vs. F4) and also for patients with compensated and decompensated cirrhosis. The diagnostic performance of ECVs in detecting clinically significant fibrosis (≥ F2) and cirrhosis (F4) was assessed using ROC analysis.

RESULTS: A total of 144 patients (men = 98, mean age 58.1 ± 11.5 years) were included. The ECV-iodine value was significantly higher in cirrhosis (33.6 ± 6.8 %) than those with F0 - 1 (25.0 ± 3.7 %) or F2 - 3 (28.3 ± 3.4 %, P < 0.001 for all). It was significantly higher in decompensated cirrhosis than those with compensated cirrhosis (36.5 ± 7.2 % vs. 30.7 ± 5.0 %, respectively; P < 0.001). The AUC of ECV-iodine was 0.82 for detecting F2 or above (cut-off value, > 26.9 %) and 0.81 for detecting cirrhosis (cut-off value, > 29 %). ECV-iodine had a significantly higher AUC than ECV-HU for detecting F2 or above (AUC: 0.69, P < 0.001) and cirrhosis (AUC: 0.74, P = 0.04).

CONCLUSIONS: ECV-iodine from spectral CT was able to detect clinically significant hepatic fibrosis and cirrhosis.

来源:Eur J Radiol,查看原文。版权归原作者所有。

引用

  1. Yoon JH, Lee JM, Kim JH, et al. Hepatic fibrosis grading with extracellular volume fraction from iodine mapping in spectral liver CT. Eur J Radiol. 2021. PMID: 33618210. doi:10.1016/j.ejrad.2021.109604

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。